DrugPatentWatch

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Generic Name: amlodipine besylate; telmisartan

Summary for Generic Name: amlodipine besylate; telmisartan

Tradenames:2
Patents:1
Applicants:3
NDAs:3
Drug Master File Entries: see list44
Suppliers: see list1

Pharmacology for Ingredient: amlodipine besylate; telmisartan

Clinical Trials for: amlodipine besylate; telmisartan

Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension
Status: Completed Condition: Hypertension

Telmisartan, Amlodipine and Combination in Healthy Subjects
Status: Completed Condition: Healthy

CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin)
Status: Completed Condition: Hypertension; Hyperlipidemia

Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine
Status: Completed Condition: Essential Hypertension; Hyperlipidemia

Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension
Status: Completed Condition: Hypertension

A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients
Status: Completed Condition: Hypertension; Obesity

Telmisartan and Amlodipine Versus Monocomponent Tablets
Status: Completed Condition: Hypertension

Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension
Status: Completed Condition: Hypertension

Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Doses of 40 mg Telmisartan/5 mg Amlodipine and 80 mg Telmisartan/5 mg Amlodipine in Healthy Male Volunteers
Status: Completed Condition: Healthy

Compare Efficacy and Safety of Telmisartan/Hydrochlorothiazide With Telmisartan/Hydrochlorothiazide Plus Amlodipine
Status: Active, not recruiting Condition: Hypertension

Courtesy of ClinicalTrials.org
See more clinical trials for this drug

Litigation for: AMLODIPINE


Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Lupin Ltd
TELMISARTAN AND AMLODIPINE
amlodipine besylate; telmisartan
TABLET;ORAL201586Jan 8, 2014RXNo<disabled>
Torrent Pharms Ltd
TELMISARTAN AND AMLODIPINE
amlodipine besylate; telmisartan
TABLET;ORAL202517Jan 8, 2014RXNo<disabled>
Boehringer Ingelheim
TWYNSTA
amlodipine besylate; telmisartan
TABLET;ORAL022401Oct 16, 2009RXNo5,591,762<disabled>YYTREATMENT OF HYPERTENSION
Boehringer Ingelheim
TWYNSTA
amlodipine besylate; telmisartan
TABLET;ORAL022401Oct 16, 2009RXYes5,591,762<disabled>YYTREATMENT OF HYPERTENSION
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc